2025 fourth_quarter Filing
Q4Lobbying Activities
Policies impacting vaccine access, disease prevention programs, and prescription drug labeling requirements.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.